LINDSEY COX: Open Payments
NPI 1184969495 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$719 in 39 payments from 27 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $719
Food & beverage: $719
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 4 | $69 |
| BeOne Medicines USA, Inc. | 3 | $55 |
| Genentech USA, Inc. | 2 | $48 |
| Regeneron Healthcare Solutions, Inc. | 1 | $39 |
| Daiichi Sankyo Inc. | 2 | $39 |
| Eisai Inc. | 2 | $36 |
| Aveo Pharmaceuticals, Inc. | 2 | $35 |
| ABBVIE INC. | 2 | $35 |
| Kite Pharma, Inc. | 2 | $34 |
| Lilly USA, LLC | 2 | $28 |
Products named: KEYTRUDA, LYNOZYFIC, TEVIMBRA, Lenvima, FOTIVDA, Yescarta, VERZENIO, Polivy.
Industry payments across NE — which companies pay providers there.
